Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
1.150
-0.020 (-1.71%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Alterity Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ATHE stock has a target of 4.00, which predicts an increase of 247.83% from the current stock price of 1.15.
Analyst Consensus: Buy
* Price targets were last updated on Mar 7, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for ATHE is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Benchmark | Benchmark | Buy Reiterates $4 | Buy | Reiterates | $4 | +247.83% | Mar 7, 2024 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $20 → $10 | Strong Buy | Maintains | $20 → $10 | +769.57% | Jun 5, 2023 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +1,639.13% | Aug 3, 2022 |
Benchmark | Benchmark | Buy Initiates $40 | Buy | Initiates | $40 | +3,378.26% | Aug 20, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.